2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

SESSION

909. Medical Education and Workforce Development: Poster I

Program: Poster Abstract Session
Saturday, December 12, 2026
05:30 p.m. - 07:30 p.m.
MCCNO - Hall F
Access, Representation, Population Health, Technology and Procedures, Treatment Considerations, Combination Therapy, Drug Development, Supportive Care, Therapy Sequence, Biological Therapies, Antibody Therapy, Workforce, Adverse Events, Artificial Intelligence (AI), Generative AI, Machine Learning, Natural Language Processing, Clinical Practice (Health Services and Quality), Clinical Guidelines, Health Economics, Practice Models, Quality Improvement, Quality of Care, Systems-Based Hematology, Telemedicine, Value, Diseases, Bleeding and Clotting, Lymphoid Malignancies, Lymphoid Leukemias, Lymphomas, Myeloid Malignancies, Chronic Myeloid Malignancies, CLL, Non-Hodgkin Lymphoma, B Cell Lymphoma, Research
PAPER

2858 National survey of hematology-oncology fellows and recent graduates on continuity clinic experience and career impact

Cindy Hsin-Ti Lin, MD, Lauren M Granat, DO, MS2, Michael McNamara, MD3, James Martin, MD4
1 Cleveland Clinic, Cleveland, United States
2 Cleveland Clinic, Cleveland, United States
3 Cleveland Clinic, Cleveland, United States
4 NYU Langone Health, New York, United States

Background: 

Continuity clinic (CC) is a core component of hematology/oncology fellowship training and is generally structured as either a general oncology clinic or a disease-specific clinic. Recent curricular efforts have focused on increasing trainee exposure to community oncology practice given the changing landscape of healthcare in the United States. This study aimed to characterize H/O fellows' and recent graduates' perceived benefits and limitations of general versus disease-specific CC models, and to explore potential associations between CC structure and post-training career choice.

 

Methods: 

An anonymous survey was distributed via Microsoft Forms to program coordinators of all ACGME-accredited hematology/oncology fellowship programs nationwide (n = 194), who were asked to forward the survey to eligible fellows and recent graduates (approximately 2,303 individuals).

 

Results: 

Forty fellows and recent graduates completed the survey. Most respondents (n=23, 58%) were in their second or third year of fellowship, and 8 (20%) had already completed training. Sixteen respondents (40%) had participated in a general oncology CC and 18 (45%) in a disease-specific CC. Nearly half (n=18, 45%) had accepted or started a post-fellowship position, with academic centers being the most common practice setting (n = 8, 44%).

Compared with disease-specific clinics, respondents reported greater autonomy and more frequent experience writing chemotherapy orders in general oncology clinics. Fellows in general oncology clinics were also more likely to perceive themselves as the patient’s primary oncologist. In contrast, disease-specific clinics were associated with a higher perceived educational value-to-service ratio. The perceived level of supervision when needed was similar between the two clinic models. 

CC structure also appeared to be associated with career trajectory. Among respondents who had accepted or started positions, the most common trajectories were fellows from disease-specific CCs pursuing academic careers (n=6, 33%) and fellows from general oncology CCs pursuing community-based or hybrid careers (n=5, 28%). Approximately half of fellows who went to academic fellowship or residency programs accepted/started an academic position post-fellowship, while most fellows who went to hybrid or community-based fellowship and residency programs planned to pursue community-based careers.

Qualitative analysis of free-text responses identified several additional themes. Respondents who initially planned to pursue academic careers but ultimately accepted community positions cited financial incentives, less emphasis on research, and the opportunity to care for a broader spectrum of malignancies as factors influencing their decisions. Conversely, respondents who initially intended to enter community practice but ultimately accepted academic positions reported feeling underprepared for broad-based oncology practice due to highly disease-specific CC experiences. 

 

Conclusion: 

To our knowledge, this is the first national study evaluating hematology/oncology CC structure and its association with trainee career choice. Our findings demonstrate that both general and disease-specific CC offer distinct educational advantages and limitations that may influence trainee career selection, and that CC structure, along with fellowship and residency program type, may be associated with post-training career selection.

Several limitations of this study should be considered. Since survey distribution relied on program coordinators, the total number of fellows and recent graduates who received the survey is unknown. The overall response rate, however, was likely low, which may limit generalizability. Additionally, some respondents did not complete all survey items and recall bias may have affected recent graduates' responses.

Given the important role CC experiences play in shaping professional development and career trajectory, fellowship programs should consider an individualized and balanced approach when designing outpatient training curricula.

Cindy Hsin-Ti Lin, MD: No relevant conflicts of interest to declare.